DRIEHAUS CAPITAL MANAGEMENT LLC – Halozyme Therapeutics, Inc. Transaction History
DRIEHAUS CAPITAL MANAGEMENT LLC portfolio value:
$53.23M
portfolio value
DRIEHAUS CAPITAL MANAGEMENT LLC quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +4.98% | 63.89K shares | -3.19M | $39.54 | 1.34M |
| Q2 2022 | share | Increase | +51.94% | 438.42K shares | 22.76M | $44 | 1.28M |
| Q1 2022 | share | Increase | +44.31% | 259.15K shares | 10.14M | $39.88 | 844.06K |
| Q4 2021 | share | Decrease | -29.62% | -246.18K shares | -10.29M | $40.32 | 584.91K |
| Q3 2021 | share | Increase | +46.72% | 264.63K shares | 8.08M | $40.68 | 831.09K |
| Q2 2021 | share | Increase | +24.49% | 111.44K shares | 6.75M | $45.41 | 566.45K |
| Q1 2021 | share | Increase | +59.68% | 170.06K shares | 6.79M | $41.69 | 455.01K |
| Q4 2020 | share | Increase | +8.00% | 21.09K shares | 5.23M | $42.71 | 284.94K |
| Q3 2020 | share | Increase | +6.81% | 16.81K shares | 311K | $26.28 | 263.84K |
| Q2 2020 | share | Increase | +3.13% | 7.50K shares | 2.31M | $26.81 | 247.03K |
| Q1 2020 | share | Increase | 0.00% | 239.53K shares | 4.30M | $17.99 | 239.53K |